DEVELOPMENTAL ASPECTS OF 2-ACETAMIDOFLUORENE METABOLISM AND MUTAGENIC ACTIVATION IN THE CHICK

被引:7
作者
HAUG, LT
DYBING, E
THORGEIRSSON, SS
机构
[1] NATL INST PUBL HLTH,DEPT TOXIKOL,OSLO,NORWAY
[2] NCI,CHEM PHARMACOL LAB,BETHESDA,MD 20205
关键词
D O I
10.3109/00498258009033820
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:863 / 872
页数:10
相关论文
共 39 条
  • [21] LOWRY OH, 1951, J BIOL CHEM, V193, P265
  • [22] MACLEOD SM, 1972, J PHARMACOL EXP THER, V183, P489
  • [23] SOME FACTORS DETERMINING THE CONCENTRATION OF LIVER PROTEINS FOR OPTIMAL MUTAGENICITY OF CHEMICALS IN THE SALMONELLA-MICROSOME ASSAY
    MALAVEILLE, C
    KUROKI, T
    BRUN, G
    HAUTEFEUILLE, A
    CAMUS, AM
    BARTSCH, H
    [J]. MUTATION RESEARCH, 1979, 63 (02): : 245 - 258
  • [24] MILLER JA, 1970, CANCER RES, V30, P559
  • [25] NEBERT DW, 1972, FED PROC, V31, P1315
  • [26] OMURA T, 1964, J BIOL CHEM, V239, P1964
  • [27] LIGAND PARTITIONING INTO MEMBRANES - ITS SIGNIFICANCE IN DETERMINING KM AND KS VALUES FOR CYTOCHROME-P-450 AND OTHER MEMBRANE-BOUND RECEPTORS AND ENZYMES
    PARRY, G
    PALMER, DN
    WILLIAMS, DJ
    [J]. FEBS LETTERS, 1976, 67 (02) : 123 - 129
  • [28] EPITHELIAL TUMOURS IN FOWLS INDUCED BY 2-ACETYLAMINOFLUORENE
    PEACOCK, PR
    PEACOCK, A
    [J]. BRITISH JOURNAL OF CANCER, 1954, 8 (01) : 147 - &
  • [29] POLAND A, 1971, MOL PHARMACOL, V7, P697
  • [30] POWIS G, 1976, XENOBIOTICA, V6, P69, DOI 10.3109/00498257609151616